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Department of Deuelopm ental Therapeutics , The Uniuersity of Texas M.D. Anderson Hospital and Tumor 
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Twenty-six patients undergoing chemotherapy for acute leukem ia on a protected 
environment-prophylactic ant ibiotic program were randomly ass igned to bathe wit h either 
P -300 or a 3% hexachlorophene preparation. Both agents substantially reduced the microbial 
flora of t he skin , but t he latter preparation was slight ly more effective. The bacte riostatic 
compounds in both preparations were absorbed t hrough the skin but no toxic effects were 
observed. 
Leukemic patients a re subject to frequen t and 
serious infectious complications. Consequent ly, 
methods for protecting t hese patients from infec-
tion during remiss ion-induction chemotherapy a re 
being investigated. Severa l studies have demon-
strated that t he frequency of infections can be 
reduced by the use of pat ient isolation units and 
prophylactic ant ibiotic regimens [1 -3 J. However, 
despite t hese in tensive prophylactic measures, 
some pat ients still develop seri ous infections [4 ]. 
Although skin cleansing prepa rations have been 
included in t he prophylactic regimens, potentia lly 
pathogenic organisms may persist on the skin and 
serve as a source of infections [5]. Consequent ly, 
we have been conducting studies of soap prepara-
tions to determine the most effective sk in cleans-
ing regimen. 
P-300 is a bar soap which conta ins t he bacterio-
static compounds, t rib romosalan and t riclosan . It 
is active in vitro aga inst gram-positive cocci and 
gram-negative bacilli. In a prev ious study we found 
that P -300 caused a major red uction in t he skin 
n ora and eleminated 60 % of the organ isms [6 ]. 
Therefore , we ini tiated a randomized comparative 
study of P-300 and a 3% hexachlorophene prepara-
tion (Hex). S ince there has been concern about t he 
absorpt ion of bacteriostatic compounds through 
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Abbreviations: 
CFU: colony-formin g units 
DP-300: t riclosan : 2-4-4' tr ichloro-2' -hydroxydiphe-
nyl ether 
HCP: 3% hexachlorophene 
H ex: 3% hexachlorophene preparation 
ppb: parts per billion 
TBS: trib romosal an: 3-4' -5 tribromo salicyla nalide 
t he skin , blood and urine concentrations of t ri -
bromosalan, t riciosan, and hexachlorophene were 
de termined. 
MATERIALS AND METHODS 
Twenty-six patients with acute leukemia were studi ed 
in isolat ion uni ts for periods of 2 to 14 weeks . The 
patients were ass igned according to a table of ra ndom 
nu mbers to bathe wit h either P-300 soap or Hex. Sixteen 
patients were randomized to P-300 and 10 patients were 
randomized to Hex . The P-300 soap was provided as a ba r 
supplied by the Colgate- Pa lmolive Company, Piscata-
way , New Jersey. The active bacteriostatic agents in this 
soap are 1 % 3-4' -5 tribromo salicylanal ide (tribromosa-
Ia n) and 1 % 2-4-4' trichloro-2' -hyd roxyd iphenyl ether 
(tri closan). T he H ex prepa rat ion used was pHisohex 
which was supplied by Winthrop Laboratories, New 
York, New York, and contains 3% hexachlorophene 
(HCP) . 
Semiquant itative tota l-body skin cultures were 
obtained before ini t iating t he study, and weekly afte r 
entry into the isolat ion units. Beginning 2 days prior to 
entry and during their enti re stay in the uni t, t he pat ients 
bathed twice daily wit h the ass igned soap preparation . 
The patients were provided with a sterile wash cloth and 
we re instructed to bathe t he entire skin surface vigor-
ously and thoroughly and then rinse completely . Sterile 
water was provided tor bathing. Alt hough t he patients 
were not observed during bathing, t he importance of 
careful attention to the bat hing procedure was stressed 
repeated ly. Cul tures were obtained in the morning before 
the patients bathed. 
The semiquantitative skin culture techn ique uti li zed 
has been descri bed in detail elsewhere [5 j. The body was 
di vided in to 15 sites. A sterile cul t ure set was assemb led 
which contained 15 forceps, cotton balls, assorted cups, 
and 15 culture tubes . Using forceps, 2 cotton balls , 2.5 em 
in di ameter, were moistened with a sterile solu t ion 
conta ining 10.2 gm of K ,HPO. and 1 ml of Triton X-IOO 
(Rohm and Hass Co.) per li ter of deioni zed water , 
adjusted to a pH of7 .9. Separate fo rceps and cotton balls 
were used to swab each body area . After swabbing, t he 
moist cotton balls were placed in tubes containing 5 ml of 
the above solu tion. After shaking the tubes vigorously, a 
O.l -ml a liquot was removed and inoc ulated on a sheep 
blood agar plate. An addit ional 1.0 ml was inoculated 
into thioglycollate broth (Difco). The cult ure specimens 
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were incuba ted aerobically at 37 °C for 18 to 24 hr. Colony 
counts were determined from the sheep blood agar and 
expressed as number of colony-forming units (CFU) per 
area. Because of the dilution factor each colony on the 
plate represented 50 CFUs. Organisms cultured only 
from thioglycollate broth were designated as B. This 
designation included all anaerobic organ isms regardless 
of concentration since quantitative cultures were not 
performed under anaerobic conditions . Also included 
were aerobic organ isms at concentrations too low to be 
detected on the sheep blood agar. All organisms were 
identified using conventional microbiologic methods. 
All of the patients received ora l and topical antibiotic 
regimens while in the isolation units. These regimens 
included t he application of an antibiotic ointment to the 
ears, nose, groin , and perianal areas. Each gram of this 
ointment conta ins 5 mg neomycin sulfate, 50,000 units 
nystatin, 833 mg vancomycin chloride, and 1.66 polymyx-
in B sulfate. Details of the operation of the isolation units 
and the antibiot ic regimens have been reported elsewhere 
[7,8].' All items placed into the units are presterilized by 
gas or steam autoclav ing. Results of groin and periana l 
cultures are not included in this report because the 
patients appl ied topical antibiotics to t hese areas. 
Blood and urine samples were collected once weekly 
from each patient, before the morning bath. The concen-
trations of free t ribromosalan (TBS) and free and conj u-
gated triclosan (DP·300) were determined in the samples 
from patients bathing with P-300. The concentrations of 
free and conjugated HCP were determined in the samples 
from patients bathing with Hex. 
TBS ana lys is was performed by extracting a 5-ml 
sample of blood or urine with 15 ml ethyl acetate. A 10-ml 
a liquot was evaporated in a 60 °C water bath, and the 
residual was mixed thoroughly with silica gel G. An 
aliquot of the supernatant was spotted on diethylamino-
ethylcellulose-coated glass plates and developed in abso-
lute methanol followed by 7.5 % glacia l acet ic ac id in 
methanol. After drying, t he TBS spot was processed on a 
fluorescent spectrophotometer. 
For DP-300 determinations, a 3-ml sample was mixed 
with 1 ml acetate buffer solution (pH 2.2) and 10 ml 
hexane. A 2.5-m l a liquot was evaporated in a 60°C water 
bath and a 1: 1 mixture of acetic anhydride and pyridine 
was added. The mixture was incubated in a 60°C water 
bath and an a liquot was processed in a Hewlett Packard 
7610 gas ch romatograp h. Conjugated DP-300 was deter-
mined in blood samples by first hydrolyzi ng 3-ml samples 
with 2 ml of concentrated HCI and boiling for 60 min. 
Conjugated DP-300 was determined in urine samples by 
adding 501'1 glus ulase (Endo Laboratories) and incubat-
ing at 37 °C for 24 hr. 
Browning et a I's method was used for HCP determina-
tions 191. Conjugated HCP was determined by hydrolyz-
ing as above . 
RESULTS 
Bathing with either P-300 or Hex resulted in a 
major reduction in the number of CFUs on each 
body site. The median number of CFUs ranged 
from 400 to 6500 prior to use of t hese soaps (Tab. I). 
After 1 week of bathing, t he median number of 
CFUs was reduced to 0 to 100 per body site by 
P-300 and to 0 to 50 per body site by Hex. 
Thereafter, with both soaps the median number of 
CFUs on a ll body sites remained either at 0 or 
detectable 111 thioglycollate broth only. One 
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patient using each soap had consistently high 
numbers of CFUs on multiple body sites despite 
careful bathing. Two additional patients (one 
bathing with each soap) had consistently high 
numbers of CFUs on a single body site. 
Table II shows the proportion of patients using 
each soap who had more than 100 CFUs by body 
site during the first 6 weeks of t he study . In 
general, t his proportion was higher among t he 
patients who bathed with P-300, but none of the 
differences was statistically significant. The differ-
ences were greatest for t he cu lt ures of t he face and 
neck. The proportions of patients with more than 
100 CFUs increased sporadically for most body 
sites with both soaps during the study. 
The bacteria and fungi cultured from the 
patients prior to bathing with P-300 or Hex and 
during the study are listed in Table Ill. P-300 
eliminated 57 of 91 organisms (63%) within 2 
weeks, whereas Hex eliminated 48 of 66 organisms 
(73 %). Fifteen of the 91 organ isms (16 %) were first 
cultured after patients began bathing with P-300, 
whereas 10 of the 66 organisms (15%) were first 
cultured after patients began bathing with Hex. 
There was an average of 1 new organism acquired 
per patient after they began bathing with either 
soap. Gram-negative bacilli were acquired by 2 
patients while bathing with Hex , but by none who 
bathed with P-300. P-300 was less effective than 
Hex against diphtheroids and Propionibacterium 
sp., but these differences were not statistically 
significant. Both soaps eli minated a ll iso lates of 
Staphylococcus aureus and most isola tes of Strep-
tococcus sp. 
Generally, patients bathing with P-300 had no 
detectable free DP-300 in the blood either during 
t he first 3 weeks of bathing or subsequently (Tab. 
IV). DP-300 is absorbed through the skin, since 
conjugated DP-300 was detected in 82 % of the 33 
blood samples collected during the first 3 weeks 
and in 88% of the 60 blood samples collected 
during the subsequent weeks. Concentrations 
of free and conjugated DP-300 never exceeded 500 
ppb in the blood. Both free and conjugated DP-300 
were detected in the urine samples. During the first 
3 weeks, 72 % of these samples contained free 
DP-300 and 95 % contained conjugated DP-300. 
Subsequently , 88% of the urine samples contained 
free DP-300 and 86% contained conjugated DP-
300. There was no evidence of accumulation of 
free or conjugated DP-300, since concentrations 
were not higher subsequently than during the first 
3 weeks. However, the concentrations of free DP-
300 in the urine tended to be higher after the first 
3 weeks. Free TBS was detected in blood samples 
but not in urine samples. During the first 3 weeks 
of bathing, 88% of blood samples contained free 
TBS, genera lly at concentrations of less than 500 
ppb. Of the samples collected subsequently, 87% 
contained free TBS, and concentrations greater 
than 500 ppb were detected infrequently. There 
was some accumulation of free TBS in the blood, 
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TABLE I. Effec t of bathing on the number or organisms cultured from the skin 
Preentry Week I Week 2 Week 3 Week 4 Week 5 Week 6 
Site Soap Me· 
dian/I 
Scalp P-300 450 
Hex 3,300 
Face P-300 2,725 
Hex 6,500 
Neck P-300 2,350 
Hex 6,025 
R. Arm P-300 500 
Hex 1,150 
L. Arm P-300 400 
Hex 1,225 
R. Chest P-300 1,475 
Hex 925 
L. Chest P-300 600 
Hex I ,BOO 
Abdomen P -300 2,275 
Hex 600 
Back P-300 950 
Hex 1,950 
R. Buttock P-300 1,675 
Hex 2,975 
L. Buttock P-300 550 
Hex 825 
R. Leg P-300 1,500 
Hex 1,800 
L. Leg P-300 1,550 
Patients 
Hex 1,025 
P-300 
Hex 
16 
10 
Highest" Me- Me- Me- Me- Me- Me- High-dian Highest dian Highest di an Highest dian Highest di an Highest dia n est 
29,750 Bo 
21,050 B 
47 ,350 100 
105,000 50 
57,000 100 
50,000 B 
10,500 B 
15,500 B 
10,500 B 
55,000 B 
90,850 B 
12, 100 B 
92,450 50 
11 ,550 B 
20,150 B 
14,100 B 
27, 100 B 
48,000 B 
18,500 B 
20,650 0 
20,050 B 
1,000,000 B 
20,000 0 
11 ,300 B 
15,000 B 
102,000 B 
- 16 
- 10 
1,000 0 1,200 0 
100 0 100 0 
7,500 B 10,000 B 
3,200 B 550 B 
9.400 B 12,500 0 
300 B 600 0 
300 B 900 0 
350 B 1,850 B 
350 B 800 0 
B B 700 0 
1,700 B 950 0 
1,950 B 50 B 
950 B 850 0 
1,000 B 300 0 
1,100 B 1,100 0 
6,000 B 3,800 0 
5,200 B 350 0 
150 B 300 0 
3,250 0 10,550 0 
6,800 B 17.000 0 
3,750 0 12,650 0 
6,200 0 11 ,250 0 
2,500 0 2,050 0 
6,900 B 4,250 0 
3,500 0 2,200 0 
21,000 B 3,000 0 
16 
10 
15 
10 
2,200 0 450 0 
B 0 200 0 
2,900 50 3,200 B 
200 0 800 B 
1,100 B 3,850 B 
B B 1J,400 0 
7,400 B 550 0 
5,000 B 350 0 
300 0 2,050 0 
B 0 50 0 
1,000 B 17,750 B 
550 B 150 0 
350 0 31,000 B 
2,400 0 800 0 
600 B 3,000 0 
1.650 0 100 0 
750 B 2,200 B 
600 0 200 0 
600 B 10,600 0 
3,050 0 4,700 0 
5,450 B 6,950 0 
~~O 0 ~~O 0 
250 0 300 0 
2,250 0 100 B 
400 B 2,400 0 
250 B 250 0 
15 
10 
14 
10 
350 
B 
4, 150 
150 
1,500 
250 
50 
10,350 
B 
11 ,000 
700 
150 
1,100 
1,350 
100 
1,250 
250 
50 
300 
10,000 
1,850 
350 
2,650 
1,400 
950 
350 
o 150 
o 100 
o 550 
B 50 
o 350 
B 650 
o 150 
o 2,250 
o B 
o 3,450 
o 100 
o 200 
o 2,550 
o 2,500 
o 1, 500 
o 2, 100 
o 50 
B 300 
o 7,250 
o 5,250 
o 2,900 
o 2,650 
o 300 
o 3,400 
o 0 
o 3,250 
13 
8 
" Expressed as number of co lony- forming uni ts per area . 
" B ~ Organisms which cou ld be cult ured only from th ioglycoll ate broth (see Mal erials and M elhods ). 
since higher concentrations were detected after 3 
weeks of bathing than during the first 3 weeks. 
Conjugated TBS was not detected in blood or 
urine samples. 
Free HCP was detected in 91 % of blood sa mples 
during the first 3 weeks and in a ll of t he samples 
collected subsequently. Conjugated H CP was de-
tected in a ll blood sa mples. There was evidence for 
accumulation of free H CP, since only 23 % of 
sa mples collected during the first 3 weeks con-
tained greater than 1000 ppb , compared to 45 % of 
the sam ples collected subsequen t ly. There was no 
accumulation of conjugated H CP . Free and conju-
gated HCP were detected in the urine, but t here 
was no evidence of accumulation with duration of 
bathing. 
Four of the 10 patients randomized to Hex and 5 
of t he 16 patients randomized to P-300 developed 
infectious complications after entering on the 
study (Tab. V). One patien t had documented 
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Site 
Scalp 
Face 
Neck 
R. Arm 
L.Arm 
R. Chest 
L. Chest 
Abdomen 
Back 
R. Buttock 
L. Buttock 
R. Leg 
L. Leg 
Patients 
Organism 
Bacillus 
Diphtheroids 
Lactobaci II us 
Micrococcus 
Neisseria 
S. epidermidis 
Propionibacterium 
Clostridium 
Enterobacter 
Klebsie lla 
Pseudomonas 
S. aureus 
Streptococcus 
Candida sp. 
Aspergillus sp. 
Total Strains 
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TABLE II . Patients with more than 100 CFUs at each body site 
Soap 
P-300 
Hex 
P-300 
Hex 
P-300 
Hex 
P-300 
Hex 
P-300 
Hex 
P-300 
Hex 
P-300 
Hex 
P-300 
Hex 
P-300 
Hex 
P-300 
Hex 
P-300 
Hex 
P-300 
Hex 
P-300 
Hex 
P-300 
Hex 
Preen try 
63 
80 
81 
80 
81 
80 
81 
70 
50 
70 
75 
60 
75 
70 
75 
70 
81 
70 
81 
60 
81 
70 
88 
90 
81 
80 
16 
10 
31 
o 
50 
40 
44 
40 
19 
30 
13 
o 
31 
20 
31 
20 
19 
10 
19 
10 
13 
10 
19 
20 
19 
10 
19 
20 
16 
10 
2 
13 
o 
44 
10 
25 
20 
6 
10 
25 
10 
6 
o 
13 
10 
25 
20 
13 
10 
19 
10 
19 
10 
13 
10 
13 
10 
16 
10 
Week 
3 
(% of 01/ patients) 
13 
o 
20 
10 
26 
o 
13 
20 
13 
o 
7 
10 
7 
10 
13 
10 
7 
10 
7 
10 
7 
10 
20 
20 
20 
10 
15 
10 
7 
20 
33 
10 
33 
10 
20 
10 
26 
o 
13 
10 
26 
10 
20 
o 
7 
10 
20 
o 
26 
10 
26 
10 
20 
10 
15 
10 
TABLE III. Effect of bathing on skin flora 
Number Acquired 
of after 
strains 
9 
15 
3 
14 
16 
10 
1 
o 
2 
5 
13 
1 
o 
91 
entry 
o 
1 
2 
o 
o 
o 
10 
o 
o 
o 
o 
2 
o 
15 
P-300 
Eliminated within 
2 weeks 
Number Percent 
9 
7 
2 
9 
1 
8 
2 
1 
5 
10 
57 
100 
47 
67 
64 
100 
50 
20 
100 
100 
50 
100 
80 
100 
63 
Number Acquired 
of after 
strains 
7 
8 
o 
10 
o 
10 
8 
1 
2 
1 
3 
10 
4 
1 
66 
entry 
o 
o 
o 
o 
5 
o 
1 
1 
o 
o 
1 
2 
o 
10 
Hex 
5 
7 
o 
21 
10 
14 
20 
o 
10 
o 
10 
7 
10 
7 
10 
o 
20 
7 
o 
14 
10 
7 
20 
7 
20 
14 
10 
14 
10 
6 
8 
13 
15 
o 
8 
13 
8 
13 
o 
13 
o 
13 
8 
13 
15 
25 
o 
25 
8 
25 
o 
25 
31 
13 
15 
13 
13 
8 
Eliminated within 
2 weeks 
Number Percent 
7 
6 
6 
6 
4 
1 
o 
1 
3 
9 
3 
1 
48 
100 
75 
60 
60 
50 
100 
o 
50 
100 
100 
90 
75 
100 
73 
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TABLE IV. Blood and urine concentrations of bacteriostatic compounds 
Ini tia l 3 weeks Subsequently Ini tia l 3 weeks Subsequently 
Free Free Conjugated Conjugated Conjugated Concentra- FreeTBS Conjugated FreeTBS Free HCP Free HCP tion (Ppb) DP-3oo DP-3oo DP-3oo DP-3oo HCP HCP 
---
---
B U B U B U B U B U B U B U B U B U B U 
None 4 18 32 8 6 1 8 28 5 1 6 3 0 15 0 3 0 38 3 
1- 100 16 0 1 18 24 3 2 1 0 6 3 1 46 7 2 7 0 3 14 12 5 
101 - 500 1I 0 2 3 3 4 26 0 0 6 7 6 10 0 3 2 7 2 4 4 
50 1- 1000 1 0 0 0 0 7 5 0 0 1 0 3 5 0 2 I 8 0 10 0 
> 1000 0 0 0 0 0 5 0 0 0 6 0 2 5 0 7 0 24 0 0 0 
Tota l 32 18 35 29 33 20 60 28 57 50 60 21 22 22 12 9 53 52 2 1 13 
sam ples 
B ~ Blood 
U ~ Urine 
TABLE V. Infectious complications of patien ts bathing with bacteriostatic soaps 
Organism 
Pa- Soap Infect ion Organism cultured Other sites where tient preparation persistently organ ism persisted 
from sk in 
Hex Pneumonia Unknown 
2 Hex Septicemia and rectal abscess E . coli No Throat, stool , perianal 
3 Hex Septicemia Pseudomonas No None 
4 Hex Disse minated Ca ndida Yes Throat, stool 
Dissem inated Toxoplasma 
5 P-300 Septicemia Klebsiella No Stool 
6 P-300 Septicemia and pneum onia P seudomonas Yes T hroat, stool 
Disseminated Candida No T hroat, stool 
7 P-300 Pneumonia a nd pye lone phritis Ca ndida Yes T hroat, periana, vag ina 
8 P-300 Disseminated Ca ndida No None 
9 P-300 Septicemia a nd pneumonia Co rynebacterium Yes None 
pneumonia on chest roentgenogram, bu t t he etio-
logic agent cou ld not be identified. The majority of 
infections were caused by gram- negative bacilli or 
Ca ndida sp. Three organisms causing infection 
persisted on the sk in despite t he bathing proce-
dures, b ut all 3 organ isms also persisted on other 
body sites . One patient d ied of Corynebacterium 
sp. pneumonia and septicemia. Diphtheroids per-
sisted on her skin , but it was not possible to 
determine whether t he infecting organism was 
present. The organisms causing infection which did 
not persist in skin cul t ures did persist in cu ltures 
from other body sites such as t he throat and stool. 
DISCUSS ION 
A substantial number of infections a n sll1g in 
immunosuppressed patients a re ca used by their 
endogenous microbial fl ora. Hence, methods for 
reducing this microbial burden a re an in tegra l part 
of prophylactic regimens. In add ition to ora l and 
top ical a nt ibiotics, bacteriostatic soap prepara-
t ions have been evaluated. Enteric organis ms have 
been cul tured from patients' skin long a fter t hey 
have been eliminated from the feces by ora l 
antibiotics [5 ]. These persistent organisms may 
cause se rious infections. However, t hi s and other 
studies suggest t hat most infections are caused by 
endogenous fl ora from other sites such as t he 
oropharynx and gastrointestina l tract. We have 
uti l ized the semiquanti tative tota l-body skin cu l-
t ure tec hnique to assess the efficacy of cleansing 
procedures in eli minating t he microbial fl ora of t he 
s kin. 
Hex has been used extensively as a bacterio-
static agent in soap preparations. Although it is 
efficacious aga inst S. aureus, it has been consid-
ered to have lit t le activity aga inst gram -negative 
bacilli. Regular bathing with t hese preparations 
results in accumulation of HCP on the skin with 
maximum bacteriostatic effect occurring after sev-
eral days. In vitro, P-300 inhibits not only S. 
aureus but a lso some gram-negative bacilli, includ-
ing Escherichia coli , K lebsiella sp., and Salmo-
nella sp. (J . H. Pickin, unpublished data). Our 
original study indi cated that P-300 was effective in 
eliminating both gram- posit ive and gram-negative 
organisms from t he skin [6 ]. In t his random ized, 
comparative study, P-300 was s lightly less effective 
than Hex, a lthough the d ifferences were not statis-
t ica lly s ignificant. However, only patients who 
bathed with Hex acquired new gram- negative 
bacill i on t he sk i n. 
Recently, t he use of Hex has been greatly re-
stricted because of its absorption t hrough t he skin , 
result ing in neurologic toxicity in neonates . Rats 
fed HCP develop hind leg weakness assoc iated with 
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widespread intra myelinic vacuolization and occa-
sional segmental demyelination of the sciatic nerve 
(J. H. Pickin, unpublished datal. Myelin content 
of the nerves in these animals is 40% less than in 
controls. Autopsy studies have demonstrated a 
vacuolar encephalopathy of the brainstem reticu-
lar formation in neonates who were bathed repeat-
edly with HCP [10]. The toxic effects of HCP in 
humans are related to the age of the patient, 
frequency of bathing, and the adequacy of rinsing. 
Hex is either excreted unchanged in the urine or 
conjugated in the liver and the conjugated drug is 
also excreted in the liver. Free HCP was detected 
in nearly all of the blood samples of our patients 
who bathed with Hex and the conjugated drug was 
detected in all blood samples. The concentration of 
free HCP, but not of conjugated HCP, was higher 
in blood samples collected after the patients had 
been bathing with Hex for more than 3 weeks. 
Since the concentration of conjugated drug did not 
increase, it is possible that the conjugating 
enzymes were saturated. Several patients had 
serum concentrations of free HCP in excess of 1000 
ppb. Apparently adults are not very susceptible to 
the neurologic toxicity of this compound since none 
of these patients developed any signs or symptoms 
of neurologic impairment attributable to HCP. 
Both TSB and DP-300 were absorbed through 
the skin . Free DP-300 was detected infrequently in 
the blood but was detected in the urine. Conjugat-
ed DP-300 was detected regularly in blood and 
urine samples. Hence, DP-300 probably is either 
excreted or conjugated rapidly . The amount ab-
sorbed did not appear to exceed excretory mech-
anisms since there was no ev idence of accumula-
tion with dura t ion of bathing. Free TSB was 
detected in the blood but not in the urine and 
conjugated TSB was not detected at all. Hence , it 
is not clear what the excretory mechanism for this 
compound is. No toxic effects were observed in 
patients bathing with P-300, although TBS can 
cause phototoxic ity. 
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P-300 is a bacteriostatic soap preparation which 
was comparable in efficacy to Hex in this group of 
patients with compromised host defenses. The 
bacteriostatic ingredients are absorbed through t he 
skin but not in as high concentrations as HCP . 
None of the patients who bathed regularly with 
P-300 or Hex developed any evidence of toxicity. 
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